Search Results 1211-1220 of 13604 for Incidence

  1. Hydrocodone and pseudoephedrine (oral route) - Side effects & dosage - Mayo Clinic

    Incidence not known. Itching or skin rash; weakness. Other side effects not listed may also occur in some patients. If you notice any other effects, check with ...

  2. Linagliptin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    Incidence not known. Bloating; constipation; darkened urine; fainting spells; fever; indigestion; irregular heartbeat; large, hard skin blisters; large, hive- ...

  3. A Study Evaluating the Safety and Efficacy of KITE-585 in Subjects With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    ... incidence of anti-BCMA CAR antibodies. Seventeen patients were enrolled, and 14 received KITE-585 with a median follow-up of 12.0 months. The median age of ...

  4. Colchicine (oral route) - Side effects & dosage - Mayo Clinic

    Incidence not known · Bleeding gums · chest pain or tightness · cough · dark urine · headache · high fever · muscle cramps, spasms, or stiffness · muscular pain, ...

  5. Neurology - Clinical trials

    This study aims to evaluate the safety of local delivery of AMSCs for recurrent GBM by noting the incidence of adverse events, as well as radiological and ...

  6. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to evaluate if the combination of trivalent adenovirus-5 (Tri-Ad5) vaccines and IL-15 superagonist N-803 reduces the incidence of ...

  7. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the 36-month incidence of pelvic/non-vaginal recurrence among patients with surgical stage I intermediate-risk ...

  8. Insulin lispro (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Incidence not known. Redness, swelling, or itching at the injection site. Other side effects not listed may also occur in some patients.

  9. Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer - Mayo Clinic

    Rifaximin may reduce the incidence and severity of pertuzumab induced gastrointestinal toxicities without interrupting or delaying the chemotherapy schedule.

  10. Understanding the Role of Gut Microbiome in Pathogenesis of Clostridioides Difficile Infection

    Clostridioides difficile is a leading cause of hospital-acquired infections. The incidence of C. diff is steadily increasing and is associated with ...